William D. Atchison
Ph.D., 1980, University of Wisconsin
Professor, Dept. of Pharmacology & Toxicology
- Neurotransmitter release and synaptic transmission; models of human neuromuscular disorders of peripheral and central neurotransmission, chemical neurotoxicity, ion channel pharmacology.

Timothy J. Collier
Ph.D., 1983, Northwestern University
Professor, TSMM/CHM
- Models of Parkinson’s disease to study mechanisms of degeneration and therapeutics; neurobiology of aging.

Ke Dong
Ph.D., 1993, Cornell University
Assistant Professor, Dept. of Entomology
- Insect voltage-gated ion channels, interaction between ion channels and insecticides and other neurotoxins, and molecular mechanisms of insecticide resistance

Anne McLaren Dorrance
Ph.D., 1997, University of Glasgow
Associate Professor, Dept. of Pharmacology and Toxicology
- Cerebral ischemia and cerebral vessel structure and function.

Heather L. Eisthen
Ph.D., 1992, Indiana University
Associate Professor, Dept. of Zoology
- Neuroethology, comparative and developmental vertebrate neurobiology.

James J. Galligan
Ph.D., 1983, University of Arizona
Professor, Dept. of Pharmacology & Toxicology
- Neurophysiology and pharmacology of autonomic nerves.

Joseph R. Haywood
Ph.D. 1976, University of Florida
Professor, Dept. of Pharmacology & Toxicology
- Sex differences in the neural and endocrine mechanisms of hypertension.

Colleen C. Hegg
Ph.D., 1996, University of Wisconsin - Madison
Assistant Professor, Dept. of Pharmacology & Toxicology
- Elucidating the mechanisms of neuroregeneration.

David L. Kreulen
Ph.D., 1974, Wayne State University
Professor, Dept. of Physiology, Center for Clinical Neuroscience
- Regulation of the sympathetic nervous system; relationships between sympathetic neuron properties and the regulation of blood vessels; interactions between sympathetic and sensory neurons.

András M. Komáromy*
Ph.D., 2002, Comparative Ophthalmology
Dr., 1993, University of Zurich, Veterinary Medicine
-Molecular and cellular mechanisms of inherited retinal and optic nerve diseases; gene therapy

Jack W. Lipton*
Ph.D., 1993 University of California, Los Angeles
Professor, Dept of Neurology & Opthalmology
Director, Div. of Translational Science & Molecular Medicine, College of Human Medicine
- Developmental exposure to drugs of abuse, development of the dopamine system, etiology and experimental therapeutics of Parkinson’s disease

Karim G. Oweiss
Ph.D., 2002, University of Michigan
Associate Professor, Depts. Electrical & Computer Engineering
- Neural integration and coordination in sensorimotor systems, Brain Machine Interfaces, multiscale signal processing in the nervous system.

Mary B. Rheuben
Ph.D., 1971, University of California-San Diego
Professor, Dept. of Pathobiology and Diagnostic Investigation
- Synaptic vesicle recycling and endocytosis in Drosophila neuromuscular junctions.

Caryl E. Sortwell
Ph.D., 1994, University of Illinois at Chicago
Professor, Dept of Neurology
- Experimental treatment strategies in Parkison's disease.

Kathy Steece-Collier
Ph.D., 1986, University of Illinois at Chicago
Professor, Division of Translation Science and Molecular Medicine
- Brain plasticity in neurodegenerative disease models.

Greg Swain
Ph.D., 1991, University of Kansas
Professor, Dept. Chemistry
- Neural control mechanisms of arteries and veins in hypertension, and maturation of the enteric nervous system and its regulatory function in the gastrointestinal tract.

Donna H. Wang
M.D., 1984, Sun Yan-sen University of Medical Sciences
Professor, Dept. of Medicine and Dept. of Pharmacology & Toxicology
- Cellular and molecular mechanisms underlying salt sensitive hypertension.

Hongbing Wang
Ph.D., 1998, UCLA
Assistant Professor, Depts. Physiology and Neuroscience
- Cyclic AMP signaling and neuroplasticity